Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inducible Alpha-Synuclein Expression Affects Human Neural Stem Cells' Behavior.

Jacopo Zasso1, Mastad Ahmed1, Alessandro Cutarelli1

  • 1Centre for Integrative Biology-CIBIO, Università degli Studi di Trento , Trento, Italy.

Stem Cells and Development
|April 20, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating Treatment Response in Obsessive-Compulsive Disorder Through Neuromodulation and Patient-Derived Induced Pluripotent Stem Cell Models: Preliminary Clinical Observations from a Translational Study.

Brain sciences·2026
Same author

Dualsteric Agonist for M2 Muscarinic Receptor Causes Oxidative Stress and Mitochondrial Alteration in Human Glioblastoma Cancer Stem Cells.

Journal of neurochemistry·2026
Same author

Lithium ameliorates neural differentiation restoring cell death balance in Cornelia de Lange syndrome 2D and 3D models.

Cell death discovery·2026
Same author

ARHGEF6-dependent cytoskeletal regulation underlies a conserved program of forebrain interneuron development.

bioRxiv : the preprint server for biology·2026
Same author

Transcript-protein discrepancy of glutamatergic receptor subunits in human iPSC-derived neurons: Implications for neurotoxicity testing.

Toxicology letters·2026
Same author

Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma.

Experimental & molecular medicine·2026

This study introduces a new human neural stem cell model to control alpha-synuclein (aSyn) levels. The model demonstrates that increased aSyn causes cell damage and impairs neural development, offering insights into Parkinson's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Alpha-synuclein (aSyn) expression is critical in Parkinson's disease (PD).
  • Mechanisms of wild-type aSyn neurotoxicity and its role in PD pathogenesis require further clarification.
  • In vitro cellular systems are essential for studying aSyn's effects.

Purpose of the Study:

  • To develop a novel human neural stem cell (hNSC) line for controlled aSyn expression.
  • To investigate the effects of experimentally tuned aSyn levels on hNSCs and neuronal differentiation.
  • To establish a valuable tool for dissecting aSyn's pathogenic mechanisms in PD.

Main Methods:

  • Development of a Tet-on hNSC line allowing tunable aSyn expression.
  • Induction of aSyn in self-renewing hNSCs and during neuronal differentiation.
Keywords:
Parkinson's diseasealpha-synucleinhuman neural stem cellsinducible expressionneurons

Related Experiment Videos

  • Assessment of aSyn aggregation, cell proliferation, survival, and differentiation outcomes.
  • Evaluation of acute aSyn toxicity in hNSC-derived dopaminergic neurons.

    • Main Results:

    • Induced aSyn expression led to aggregate formation, impaired proliferation, and reduced survival in hNSCs.
    • aSyn induction during differentiation resulted in decreased neurogenesis and increased glial/undifferentiated cells.
    • Acute aSyn exposure caused toxicity in dopaminergic neurons derived from hNSCs.

    Conclusions:

    • The novel conditional hNSC model enables precise control over aSyn expression.
    • This model effectively recapitulates aSyn-induced cellular pathologies relevant to Parkinson's disease.
    • The system provides a valuable platform for future research into aSyn pathogenesis and therapeutic strategies for PD.